• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

邻苯二甲酸酯通过增强妊娠相关 X 受体和 E26 转化特异性序列 1 之间的相互作用促进肝细胞癌细胞的侵袭。

Phthalates promote the invasion of hepatocellular carcinoma cells by enhancing the interaction between Pregnane X receptor and E26 transformation specific sequence 1.

机构信息

Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, PR China.

Department of Hepatobiliary and Pancreatic Surgery/Open and Key Laboratory of Hepatobiliary & Pancreatic Surgery and Digestive Organ Transplantation at Henan Universities/ZhengZhou Key Laboratory of Hepatobiliary & Pancreatic Diseases and Organ Transplantation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, PR China.

出版信息

Pharmacol Res. 2021 Jul;169:105648. doi: 10.1016/j.phrs.2021.105648. Epub 2021 May 6.

DOI:10.1016/j.phrs.2021.105648
PMID:33965509
Abstract

Phthalates (PAEs) are considered endocrine-disrupting chemicals (EDCs), a series of compounds able to disrupt the normal regulation of the human endocrine-system. In the present study, we investigated the roles of four PAEs, butyl benzyl phthalate (BBP), dibutyl phthalate (DBP), dimethyl phthalate (DMP), and diethyl phthalate (DEP), in hepatocellular carcinoma (HCC) cells. We define novel roles for the PAEs on the migration of HCC cells via their enhancing of the interaction between the pregnane X receptor (PXR) and E26 transformation specific sequence 1 (ETS-1). Our results indicate that PAEs induced the transcriptional activation of ETS-1 and PXR. PXR activated by PAEs could bind to ETS-1 directly and enhanced the activity of ETS-1, which resulted in the induction of invasion-related ETS-1 target genes. The "LXXLL" motif in the ETS-1C-terminal was essential for the interaction between PXR and ETS-1 induced by PAEs. Treatment of PAEs promoted the nuclear accumulation of ETS-1 or the recruitment of ETS-1, but not in cells expressing ETS-1 with a mutated LXXLL motif in its downstream gene promoter region, or following transfection of PXR siRNA. Treatment with the PXR antagonist ketoconazole almost completely inhibited the effects of PAEs. Moreover, PAEs enhanced the in vitro or in vivo invasion of HCC cells via PXR/ETS-1. Therefore, our results not only contribute to a better understanding of HCC, but also extended the roles of EDCs regulating human malignancies.

摘要

邻苯二甲酸酯(PAEs)被认为是内分泌干扰化学物质(EDCs),是一系列能够破坏人体内分泌系统正常调节的化合物。在本研究中,我们研究了四种 PAEs,即邻苯二甲酸丁基苄基酯(BBP)、邻苯二甲酸二丁酯(DBP)、邻苯二甲酸二甲酯(DMP)和邻苯二甲酸二乙酯(DEP),在肝癌(HCC)细胞中的作用。我们通过研究发现,PAEs 通过增强妊娠相关 X 受体(PXR)和 E26 转化特异性序列 1(ETS-1)之间的相互作用,对 HCC 细胞的迁移发挥了新的作用。我们的结果表明,PAEs 诱导了 ETS-1 和 PXR 的转录激活。PAEs 激活的 PXR 可以直接与 ETS-1 结合,并增强 ETS-1 的活性,从而诱导侵袭相关的 ETS-1 靶基因的诱导。PAEs 诱导的 PXR 和 ETS-1 之间的相互作用需要 ETS-1 末端的“LXXLL”基序。PAEs 的处理促进了 ETS-1 的核积累或募集,而不是在表达 ETS-1 的细胞中,或者在其下游基因启动子区域中具有突变的“LXXLL”基序的 ETS-1 或在用 PXR siRNA 转染后。用 PXR 拮抗剂酮康唑处理几乎完全抑制了 PAEs 的作用。此外,PAEs 通过 PXR/ETS-1 增强了 HCC 细胞的体外或体内侵袭。因此,我们的研究结果不仅有助于更好地了解 HCC,而且扩展了 EDCs 调节人类恶性肿瘤的作用。

相似文献

1
Phthalates promote the invasion of hepatocellular carcinoma cells by enhancing the interaction between Pregnane X receptor and E26 transformation specific sequence 1.邻苯二甲酸酯通过增强妊娠相关 X 受体和 E26 转化特异性序列 1 之间的相互作用促进肝细胞癌细胞的侵袭。
Pharmacol Res. 2021 Jul;169:105648. doi: 10.1016/j.phrs.2021.105648. Epub 2021 May 6.
2
ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR.ETS-1 通过调节 PXR 转录因子活性诱导肝癌细胞对索拉非尼耐药。
Pharmacol Res. 2018 Sep;135:188-200. doi: 10.1016/j.phrs.2018.08.003. Epub 2018 Aug 13.
3
Benzyl butyl phthalate induces migration, invasion, and angiogenesis of Huh7 hepatocellular carcinoma cells through nongenomic AhR/G-protein signaling.邻苯二甲酸苄基丁酯通过非基因组AhR/G蛋白信号通路诱导Huh7肝癌细胞的迁移、侵袭和血管生成。
BMC Cancer. 2014 Aug 1;14:556. doi: 10.1186/1471-2407-14-556.
4
TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR.TGF-β 诱导的肝癌化疗耐药性受外源性核受体 PXR 调节。
Cell Cycle. 2019 Dec;18(24):3589-3602. doi: 10.1080/15384101.2019.1693120. Epub 2019 Nov 18.
5
Pregnane X receptor (PXR) deficiency promotes hepatocarcinogenesis via induction of Akr1c18 expression and prostaglandin F (PGF) levels.妊娠相关 X 受体(PXR)缺失通过诱导Akr1c18 表达和前列腺素 F(PGF)水平促进肝癌发生。
Biochem Pharmacol. 2024 Jul;225:116309. doi: 10.1016/j.bcp.2024.116309. Epub 2024 May 22.
6
Fate of four phthalate esters with presence of Karenia brevis: Uptake and biodegradation.四种类邻苯二甲酸酯在具齿原甲藻存在下的归宿:吸收和生物降解。
Aquat Toxicol. 2019 Jan;206:81-90. doi: 10.1016/j.aquatox.2018.11.010. Epub 2018 Nov 12.
7
Novel small molecule inhibitors of the transcription factor ETS-1 and their antitumor activity against hepatocellular carcinoma.新型 ETS-1 转录因子小分子抑制剂及其对肝癌的抗肿瘤活性。
Eur J Pharmacol. 2021 Sep 5;906:174214. doi: 10.1016/j.ejphar.2021.174214. Epub 2021 Jun 8.
8
Study on the Mechanism of Interaction between Phthalate Acid Esters and Bovine Hemoglobin.邻苯二甲酸酯与牛血红蛋白相互作用机制的研究
J Agric Food Chem. 2016 Aug 3;64(30):6035-41. doi: 10.1021/acs.jafc.6b02198. Epub 2016 Jul 20.
9
Non-covalent binding interaction between phthalic acid esters and DNA.邻苯二甲酸酯与 DNA 的非共价结合相互作用。
Environ Int. 2022 Mar;161:107095. doi: 10.1016/j.envint.2022.107095. Epub 2022 Jan 18.
10
Inhibitory mechanism of phthalate esters on Karenia brevis.邻苯二甲酸酯对短裸甲藻的抑制机制。
Chemosphere. 2016 Jul;155:498-508. doi: 10.1016/j.chemosphere.2016.04.082. Epub 2016 May 2.

引用本文的文献

1
Integrative analysis based on ATAC-seq and RNA-seq reveals a novel oncogene PRPF3 in hepatocellular carcinoma.基于 ATAC-seq 和 RNA-seq 的综合分析揭示了肝癌中的一个新癌基因 PRPF3。
Clin Epigenetics. 2024 Nov 5;16(1):154. doi: 10.1186/s13148-024-01769-w.
2
Novel structured ADAM17 small-molecule inhibitor represses ADAM17/Notch pathway activation and the NSCLC cells' resistance to anti-tumour drugs.新型结构的ADAM17小分子抑制剂可抑制ADAM17/Notch信号通路激活及非小细胞肺癌细胞对抗肿瘤药物的耐药性。
Front Pharmacol. 2023 Jun 29;14:1189245. doi: 10.3389/fphar.2023.1189245. eCollection 2023.
3
NIO-1, A Novel Inhibitor of OCT1, Enhances the Antitumor Action of Radiofrequency Ablation against Hepatocellular Carcinoma.
NIO-1,一种新型 OCT1 抑制剂,增强了射频消融治疗肝癌的抗肿瘤作用。
Curr Mol Med. 2024;24(5):637-647. doi: 10.2174/1566524023666230526154739.
4
Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism.用于肝细胞癌治疗的金属有机框架及其作用机制
Front Pharmacol. 2022 Sep 26;13:1025780. doi: 10.3389/fphar.2022.1025780. eCollection 2022.
5
Diagnostic accuracy and prognostic significance of Glypican-3 in hepatocellular carcinoma: A systematic review and meta-analysis.Glypican-3在肝细胞癌中的诊断准确性及预后意义:一项系统评价与Meta分析
Front Oncol. 2022 Sep 23;12:1012418. doi: 10.3389/fonc.2022.1012418. eCollection 2022.
6
MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells.MTBP增强转录因子ETS-1的激活并促进肝癌细胞的增殖。
Front Oncol. 2022 Aug 29;12:985082. doi: 10.3389/fonc.2022.985082. eCollection 2022.
7
The Combination of AFP and "Up-To-Seven" Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients.甲胎蛋白(AFP)与“七项标准”相结合可能是中国肝硬化肝癌患者肝移植的更好策略。
Front Oncol. 2022 Jul 12;12:959151. doi: 10.3389/fonc.2022.959151. eCollection 2022.
8
A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma.一种单核苷酸混合物增强分子靶向药物对肝细胞癌的抗肿瘤活性。
Front Pharmacol. 2022 Jun 27;13:951831. doi: 10.3389/fphar.2022.951831. eCollection 2022.
9
Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs.抑制 Tank 结合激酶 1 可增强肝癌细胞对分子靶向药物的敏感性。
Front Pharmacol. 2022 Jun 7;13:924523. doi: 10.3389/fphar.2022.924523. eCollection 2022.
10
A Novel Small-Molecule Inhibitor of SREBP-1 Based on Natural Product Monomers Upregulates the Sensitivity of Lung Squamous Cell Carcinoma Cells to Antitumor Drugs.一种基于天然产物单体的新型SREBP-1小分子抑制剂上调肺鳞状细胞癌细胞对抗肿瘤药物的敏感性。
Front Pharmacol. 2022 May 18;13:895744. doi: 10.3389/fphar.2022.895744. eCollection 2022.